200 related articles for article (PubMed ID: 30352219)
21. CSN5 Promotes Carcinogenesis of Thyroid Carcinoma Cells Through ANGPTL2.
Xie P; Wang H; Fang J; Du D; Tian Z; Zhen J; Liu Y; Ding Y; Fu B; Liu F; Huang D; Yu J
Endocrinology; 2021 Mar; 162(3):. PubMed ID: 33508120
[TBL] [Abstract][Full Text] [Related]
22. FOXM1 promotes invasion and migration of colorectal cancer cells partially dependent on HSPA5 transactivation.
Luo X; Yao J; Nie P; Yang Z; Feng H; Chen P; Shi X; Zou Z
Oncotarget; 2016 May; 7(18):26480-95. PubMed ID: 27034162
[TBL] [Abstract][Full Text] [Related]
23. Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression.
Pan Y; Wang S; Su B; Zhou F; Zhang R; Xu T; Zhang R; Leventaki V; Drakos E; Liu W; Claret FX
Oncogene; 2017 Feb; 36(8):1069-1079. PubMed ID: 27524414
[TBL] [Abstract][Full Text] [Related]
24. ITGA6 and RPSA synergistically promote pancreatic cancer invasion and metastasis via PI3K and MAPK signaling pathways.
Wu Y; Tan X; Liu P; Yang Y; Huang Y; Liu X; Meng X; Yu B; Wu M; Jin H
Exp Cell Res; 2019 Jun; 379(1):30-47. PubMed ID: 30894280
[TBL] [Abstract][Full Text] [Related]
25. TM4SF1 Promotes Metastasis of Pancreatic Cancer via Regulating the Expression of DDR1.
Yang JC; Zhang Y; He SJ; Li MM; Cai XL; Wang H; Xu LM; Cao J
Sci Rep; 2017 Apr; 7():45895. PubMed ID: 28368050
[TBL] [Abstract][Full Text] [Related]
26. FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expression.
Zhu J; Zhao J; Luo C; Zhu Z; Peng X; Zhu X; Lin K; Bu F; Zhang W; Li Q; Wang K; Hu Z; Yu X; Chen L; Yuan R
Cell Death Dis; 2022 May; 13(5):497. PubMed ID: 35614040
[TBL] [Abstract][Full Text] [Related]
27. SENP1 promotes triple-negative breast cancer invasion and metastasis via enhancing CSN5 transcription mediated by GATA1 deSUMOylation.
Gao Y; Wang R; Liu J; Zhao K; Qian X; He X; Liu H
Int J Biol Sci; 2022; 18(5):2186-2201. PubMed ID: 35342335
[TBL] [Abstract][Full Text] [Related]
28. A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis.
Huang C; Qiu Z; Wang L; Peng Z; Jia Z; Logsdon CD; Le X; Wei D; Huang S; Xie K
Cancer Res; 2012 Feb; 72(3):655-65. PubMed ID: 22194465
[TBL] [Abstract][Full Text] [Related]
29. CSN6 inhibition suppresses pancreatic adenocarcinoma metastasis via destabilizing the c-Fos protein.
Ma F; Wang H; Liu K; Wang Z; Chen S
Exp Cell Res; 2020 Jun; 391(1):112004. PubMed ID: 32289284
[TBL] [Abstract][Full Text] [Related]
30. Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1.
Zhou Y; Ji Z; Yan W; Zhou Z; Li H; Xiao Y
Oncol Rep; 2017 Aug; 38(2):837-842. PubMed ID: 28677763
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of atherogenesis by the COP9 signalosome subunit 5 in vivo.
Asare Y; Ommer M; Azombo FA; Alampour-Rajabi S; Sternkopf M; Sanati M; Gijbels MJ; Schmitz C; Sinitski D; Tilstam PV; Lue H; Gessner A; Lange D; Schmid JA; Weber C; Dichgans M; Jankowski J; Pardi R; de Winther MP; Noels H; Bernhagen J
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):E2766-E2775. PubMed ID: 28292897
[TBL] [Abstract][Full Text] [Related]
32. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
33. CSN5 attenuates Ang II-induced cardiac hypertrophy through stabilizing LKB1.
Sheng Z; Xu Y; Li F; Wang S; Huang T; Lu P
Exp Cell Res; 2019 Mar; 376(1):11-17. PubMed ID: 30710502
[TBL] [Abstract][Full Text] [Related]
34. Suppression of CSN5 promotes the apoptosis of gastric cancer cells through regulating p53-related apoptotic pathways.
Sang MM; Du WQ; Zhang RY; Zheng JN; Pei DS
Bioorg Med Chem Lett; 2015 Aug; 25(15):2897-901. PubMed ID: 26048783
[TBL] [Abstract][Full Text] [Related]
35. Psoriasin promotes invasion, aggregation and survival of pancreatic cancer cells; association with disease progression.
Liu Y; Bunston C; Hodson N; Resaul J; Sun PH; Cai S; Chen G; Gu Y; Satherley LK; Bosanquet DC; Al-Sarireh B; Tian X; Hao C; Jiang WG; Ye L
Int J Oncol; 2017 May; 50(5):1491-1500. PubMed ID: 28393239
[TBL] [Abstract][Full Text] [Related]
36. Mutant p53 driven-LINC00857, a protein scaffold between FOXM1 and deubiquitinase OTUB1, promotes the metastasis of pancreatic cancer.
Zhang W; Qian W; Gu J; Gong M; Zhang W; Zhang S; Zhou C; Jiang Z; Jiang J; Han L; Wang X; Wu Z; Ma Q; Wang Z
Cancer Lett; 2023 Jan; 552():215976. PubMed ID: 36272615
[TBL] [Abstract][Full Text] [Related]
37. Glucose-Dependent FOXM1 Promotes Epithelial-to-Mesenchymal Transition Via Cellular Metabolism and Targeting Snail in Human Pancreatic Cancer.
Kyuno T; Kohno T; Konno T; Yamaguchi H; Kyuno D; Imamura M; Kimura Y; Kojima T; Takemasa I
Pancreas; 2020 Feb; 49(2):273-280. PubMed ID: 32011531
[TBL] [Abstract][Full Text] [Related]
38. USP28 facilitates pancreatic cancer progression through activation of Wnt/β-catenin pathway via stabilising FOXM1.
Chen L; Xu Z; Li Q; Feng Q; Zheng C; Du Y; Yuan R; Peng X
Cell Death Dis; 2021 Sep; 12(10):887. PubMed ID: 34584067
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of FoxM1 by MnSOD Overexpression Contributes to Cancer Stem-Like Cell Characteristics in the Lung Cancer H460 Cell Line.
Fu Z; Cao X; Yang Y; Song Z; Zhang J; Wang Z
Technol Cancer Res Treat; 2018 Jan; 17():1533033818789635. PubMed ID: 30111255
[TBL] [Abstract][Full Text] [Related]
40. LRH1 promotes pancreatic cancer metastasis.
Lin Q; Aihara A; Chung W; Li Y; Chen X; Huang Z; Weng S; Carlson RI; Nadolny C; Wands JR; Dong X
Cancer Lett; 2014 Aug; 350(1-2):15-24. PubMed ID: 24769073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
